Commentary
In September, The New England Journal of Medicine (NEJM) published a new Moderna-sponsored study on the efficacy of the initial bivalent vaccine targeting BA.1 in comparison to the original monovalent booster.
A COVID-19 vaccine in Washington in a May 6, 2021, file image. Chip Somodevilla/Getty Images
Rav Arora
Author
Rav Arora is an independent journalist based in Vancouver, Canada. He has appeared on The Ben Shapiro Show, Jordan B. Peterson Podcast, The Hill, and other programs. His Substack newsletter on mental health, spirituality, and vaccine side effects is “Noble Truths with Rav Arora.” Follow him on Twitter at @ravarora1
